<div class="stakeholder-note">

Feedback is welcome on any aspect of the content.<br>However, the following topics have been identified as areas where input would be particularly valuable:

* **Pharmacotherapy section** - Is the section's purpose clear and the section useful in its current definition. Are the current implementations using the same approach, or is the section's content conveyed in the Medication Summary section? 

</div>


